| KU Leuven | |
|---|---|
| Logo placeholder | |
| Location | Leuven, Belgium |
| Type | Public Research University |
| Website | kuleuven.be/eng |
| Founded | |
| Focus Areas | Neuroscience, Neurology, Psychiatry, Biomedical Research |
Ku Leuven is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
KU Leuven (Katholieke Universiteit Leuven) is the oldest university in the Low Countries and one of Europe's leading research universities. Located in Leuven, Belgium, KU Leuven has a distinguished history dating back to 1425. The university is renowned for its biomedical research, particularly in the fields of neuroscience, neurology, and neurodegenerative disease research.
KU Leuven's research in neurodegeneration is conducted through the KU Leuven Institute for Neuroscience and the UZ Leuven university hospital. The institution is a major European center for Alzheimer's disease, Parkinson's disease, and ALS research, with numerous breakthrough discoveries in disease genetics and mechanisms.
| Year | Achievement |
|---|---|
| 1995 | Discovery of presenilin mutations causing familial Alzheimer's disease |
| 2000s | Major contributions to understanding APP processing and amyloid biology |
| 2015 | Discovery of novel ALS genes and mechanisms |
| 2018 | Establishment of the Leuven Brain Institute |
| 2020 | Leadership in European Alzheimer's disease research consortia |
KU Leuven offers comprehensive training in neuroscience through:
The study of Ku Leuven has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Page created: 2026-03-04